Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
- Status
- COMPLETED
- Phase
- PHASE2
RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS
- Status
- UNKNOWN
- Phase
- PHASE3
RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Belimumab With Rituximab for Primary Membranous Nephropathy
- Status
- RECRUITING
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Split-Dose R-CHOP for Older Adults With DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
- Status
- RECRUITING
- Phase
- PHASE3
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
- Status
- COMPLETED
- Phase
- PHASE3
Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
- Status
- TERMINATED
- Phase
- PHASE1
Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2